ArticleThe Lancet regional health. Europe2024

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.

Karlijn Verkerk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.